Ven Ajahn Siripanyo.

The billionaire heir who became a monk – why the son of Malaysia’s third-richest man, Ananda Krishnan, renounced luxury and fortune for spiritual peace.

Would you give up billions for spiritual servitude? Thai-Malaysian monk Ven Ajahn Siripanyo, the only son of Malaysian billionaire Ananda Krishnan, did just that.

Spiritual Peace n Universal Wisdom.

yttihs.
That’s why I call that forum gangster forum. Only OTB there is more like a man.
26/07/2020 2:14 AM

Wa...u n Noobie33...talk until after 2am...◉‿◉...I personally don't trust Supermax management...Datuk Seri are just running dogs...Tan Sri are ordering them...◉‿◉... sometimes people say...have u seen a big snake defecates... That's why Supermax people are like this...Money is very dirty...but within that...we got to change our habits n attitudes to be a better person...when u are quite stable. Life isn't all about money...find happiness n peace... that's what some people here are doing...so we cannot force others to be like us...｡◕‿◕｡

HANOI: Vietnam was back on high alert for the novel coronavirus on Saturday (Jul 25) after medical officials in the central city of Danang detected what appears to be the first local COVID-19 case in the Southeast Asian country for three months.

Thanks to strict quarantine measures and an aggressive and widespread testing programme, Vietnam has kept its virus total to an impressively low 415 cases, and had reported no locally transmitted infections for 100 days.

Vietnam has reported no deaths from the virus.

READ: Commentary: Vietnam is emerging a lot stronger from this coronavirus outbreak
But on Friday, Vietnam's health ministry said in a statement that a 57-year-old man from Danang, a popular tourist hotspot, had tested positive for the virus, prompting the isolation of 50 people he came in contact with.

The ministry said 103 people connected to the patient were tested for the virus but all returned negative results.

Advertisement

The government said on Saturday a new test had confirmed the man's infection, bringing the total number of cases in Vietnam to 416.

It did not say how the man contracted the virus, but said he had not left Danang for nearly a month. He was initially diagnosed with pneumonia.

The case comes at a time when Vietnam was about to resume international commercial flights and as domestic tourism is surging.

Late on Friday, authorities in Hanoi reinstated a recommendation to wear masks in public places as Vietnam's benchmark VN Index closed down 3.22 per cent.

The country's ban on international commercial flights is still in place, but foreign experts and skilled workers have been able to enter Vietnam throughout the pandemic provided they undergo mandatory centralised quarantine.

READ: Coronavirus-free UK pilot, symbol of Vietnam's pandemic success, to return home
Of the nearly 150 cases reported over the past three months, all were imported and the people quarantined on arrival. Earlier this week, Vietnam said it would repatriate around 130 Vietnamese citizens infected with the virus from Equatorial Guinea.

In March, Danang reported six local cases of the coronavirus as the US aircraft carrier Theodore Roosevelt conducted a port visit to the city.

Coronavirus vaccine may be available in Singapore only at the end of next year: MOH
A research officer checks the quality of cells and virus that are used in the development of a vaccine.
A research officer checks the quality of cells and virus that are used in the development of a vaccine.ST PHOTO: KELVIN CHNG
PUBLISHEDJUL 24, 2020, 7:00 PM SGT
FACEBOOKTWITTER
Rei Kurohi
SINGAPORE - A Covid-19 vaccine may become available in sufficient doses only towards the end of next year, the Health Ministry director of medical services Kenneth Mak said.

He said Singapore is proactively working with vaccine developers, pharmaceutical companies and research institutions on research efforts into a Covid-19 vaccine.

Discussions have also begun to ensure Singapore will have access to vaccines when they become available, he told a virtual press conference on Friday (July 24).

But even though a number of companies have announced that they have started on phase three trials, which are a "relatively later stage" of the process of vaccine development, Associate Professor Mak said there may yet be failures in delivering a vaccine that is safe and effective.

"Practically speaking, we expect, realistically, a vaccine to be available perhaps next year rather than this year," he said.

"Given the global demand for these vaccines, it may not even be in the beginning of next year but perhaps towards the end of next year, when we might see vaccines produced in sufficient doses, and available then for procurement and to be delivered into Singapore."

He added that at this stage, it is still not known which of the vaccine candidates undergoing trials will ultimately be the one that is most likely to be brought into Singapore.

AirAsia Indonesia is offering drive-through rapid COVID-19 testing for passengers leaving from Soekarno-Hatta International Airport in Tangerang, Banten.

The service is provided daily from 4 a.m. to 8 p.m. for Rp 95.000 (US$6.51) at Soewarna Business Park located at the airport.

To use the service, passengers are required to show their booking ID and identity card. After registering and completing payment, a sample will be taken and passengers are to wait 10 to 15 minutes for the result.


The rapid test results and medical certificate will be valid for 14 days.

In a statement, AirAsia Indonesia director Veranita Yosephine said, “The service will be expanded to Indonesian cities that AirAsia currently serves.”

The airline has gradually resumed its operations and is now serving domestic routes from Jakarta to Medan, Surabaya, Bali, Lombok and Yogyakarta.

Earlier this month, AirAsia Indonesia updated its baggage policy and announced that passengers could bring two carry-on bags with certain requirements.

The total maximum weight for both bags should be 7 kilograms, otherwise they will be placed with checked baggage.

AirAsia Indonesia provides a free baggage allowance of up to 15 kg for domestic flights. (wng)

The Supply Chain to Save the World Is Unprepared for a Vaccine.
By Brendan Murray and Riley Griffin

July 25, 2020, 2:00 AM EDT
Freight companies say they need a coordinated strategy fast
Air cargo capacity has shrunk and shipping costs are elevated

Covid-19 Pandemic Lessons Learned for U.S. and China
Supply Lines is a daily newsletter that tracks Covid-19’s impact on trade. Sign up here, and subscribe to our Covid-19 podcast for the latest news and analysis on the pandemic.

The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the challenges of shipping an eventual Covid-19 vaccine from drugmakers to billions of people.


Already stretched thin by the pandemic, freight companies face problems ranging from shrinking capacity on container ships and cargo aircraft to a lack of visibility on when a vaccine will arrive. Shippers have struggled for years to reduce cumbersome paperwork and upgrade old technology that, unless addressed soon, will slow the relay race to transport fragile vials of medicine in unprecedented quantities.

Making a vaccine quickly is hard enough but distributing one worldwide offers a host of other variables, and conflicting forces may work against the effort: The infrastructure powering the global economy is scaling down for a protracted downturn just as pharmaceutical companies need to scale up for the biggest and most consequential product launch in modern history.

“We’re not prepared,” Neel Jones Shah, global head of air carrier relationships at San Francisco-based freight forwarder Flexport, said during a webinar this week with other logistics executives.


“Let’s all be honest here, vaccine supply chains are exponentially more complex than PPE supply chain,” he said, referring to personal protective equipment like surgical masks and gloves. “You can’t ruin PPE by leaving it on the tarmac for a couple of days. You will destroy vaccines.”

8,000 Cargo Planes
Julian Sutch, head of Emirates SkyCargo’s pharmaceutical division, estimated recently that a single Boeing Co. 777 freighter can carry 1 million individual doses of a vaccine. That means airlifting double-dose regimens to protect half the world’s population would require the space in about 8,000 cargo planes.

It’s doable, but not without a coordinated global strategy. For now, what’s helping to free up air freight capacity is retrofitting idled passenger planes so they can carry products ranging from medical gear to mangoes. Emirates is using 70 passenger 777s to move cargo, according to Sutch.

The cost of air freight from Hong Kong to North America has declined

Another capacity issue involves refrigeration. Health officials have said a vaccine that eventually comes to market will likely need to be maintained at 2 to 8 degrees Celsius (35.6 to 46.4 degrees Fahrenheit) throughout the shipping process. Some newer technologies could require more advanced freezers that can keep them at a frigid minus 80 degrees Celsius. Any deviation can ruin the shots.

Among the big questions involving fairness and accessibility: Exactly how will medicine requiring such delicate and expensive transportation reach remote, impoverished areas where drones are now used to distribute pharmaceuticals?

Such details aren’t sorted out yet and shippers are aware of the need to get organized. But they’re waiting on signals from the drugmakers.


Shah said Flexport is in early discussions with a number of pharmaceutical companies involved in vaccine manufacturing that are still unsure about what they’re going to need. “To a T, they’re all extremely nervous about being able to bring these to market as quickly as people might expect,” he said.

There are more than 160 coronavirus vaccines in development, according to the World Health Organization, though only 25 are currently in human studies. The candidates furthest along are now launching late-stage trials, and have ambitions of securing an emergency use authorization from regulators before year end. That could allow for a limited availability of shots for health-care workers and other vulnerable groups.

Targeting 2021
Ultimately, countries will need far broader access to Covid-19 shots to halt the virus that has devastated economies and so far taken more than 633,000 lives globally. But by all accounts that’s not likely to occur until well into 2021 at the earliest.


In the meantime, manufacturing deals are being clinched, and facilities are getting retrofitted to produce the still-experimental shots at the risk they fail in the clinic. Though the science underscoring the inoculations is still unproven, and mass production remains a daunting task, top pharmaceutical executives speculate that distribution will pose the greatest challenge of all.

Probably Covid19 will infect us untill summer 2021.

All gloves from Malaysia n Mercator Gloves Thailand. Did I know how many palletised units of gloves...flying out from Changi these few months...so much transit of gloves n medical products like mask, PPE, etc...flown out from Changi Airport...the No. 1 transhipment Hub in SEA...Those who works in logistics will know very well...◉‿◉

Music is still...On.

kd88
Analyse yourself when the music of glove gonna to be end.
25/07/2020 2:20 PM

yttihs Let’s say your mother do 4D blackmarket business. Every rice you eat is crime. You gonna turn your mother to police. She feeds you everyday.

Aiyoo... it's unfilial to report any crime of your own parents...zero right...let the authority solve that. Even your own bros n sis...better don't. What need to do...need not do...we must understand. That's why like...LKY siblings feud... that's very bad. How your parents feel... don't make your own parents unhappy n worry...No blessings from heavens n earth...◉‿◉

Lanesra Well, somehow @geary you are right, at the end of the day. any decision is still in your hands
25/07/2020 12:02 PM

We create our own suffering n happiness...so it's up to a person heart or mind to decide...we cannot force them...◉‿◉

PhilipLayman Why Kyy did what he did...he want to maximise profits...when supermax was going at speed of 200 km an hour n top glove at 100 km an hour kyy was on supermax...when supermax slowed to 150 km and topglove increased to 150 km an hour..kyy jump train...in his belief that top glove will soon speed to 200 km while supermax is behind.I am in recipient of his scholarship money...but the blood n tears of those he victimised should be a reminder dont ever go near him..even new students in need of a scholarship..i have to atone for the "dirty" money in my ways i know how
25/07/2020 11:26 AM

Don't anyhow judge a person...we don't have any human right to condemn or dirty a person image or status. Please don't do it again...we must look deep into our own shortcomings...correct our own wrongs characters n habits...learn from mistakes...just keep in looking inwards... don't look so much outwards n look at others people mistakes n faults. Then your life will be much better n beneficial for your health n your future blessings...｡◕‿◕｡

EngineeringProfit 3.88....coming

CHEERS
25/07/2020 9:31 AM

Yup...will be as good as Supermax n TopGlove...the best ace market gloves counter...probably lot of funds haven't notice it...only retailers hentam...no restrictions like big funds...waiting for an elephant to give the green light...◉‿◉

Uncle KYY,

"I foresee Top Glove will create history in the Malaysian stock market by announcing the biggest jump in quarterly profit for a listed company".

By September...New historical earnings growth created...｡◕‿◕｡

Trump signs orders to lower prescription drug prices | https://www.klsescreener.com/v2/news/view/707045

The Mighty Retailers.

NOBODY would have guessed that the daily trading volume record on Bursa Malaysia would be broken this year. When the Covid-19 crisis hit, most people were focused on the gloom and doom from the fallout of the pandemic.

Bursa Malaysia’s trading volume and trading value hit a record 9.3 billion units and RM9.4bil on May 29.

It is also not a one-day affair.

There were many 44 days when volumes were 50% to 100% higher than the average of Bursa Malaysia’s trading volume and values of 2.7 billion units and RM2.4bil respectively in the last two years.

To be fair, it is not just a Malaysian phenomenon, a few other markets, for example those in the United States and Hong Kong also experienced similar surges in trading volumes.

The “star” contributors to the surge in trading volume are not the usual big local institutions.

It is also not contributed by strong inflows from global foreign institutional funds.

There is no foreign “hot money” this time. In fact, foreign institutions have been selling Malaysian stocks since two years ago and remained very much absent this time around.

Retail investors were big contributors to the high trading volumes this year. Retail participation reached a high of 40% last month. Many people would not have believed it, especially if one were to study the slow decline in retail participation on Bursa Malaysia over the last 10 years.

In 2009, retail participation was over 30% and it has gradually dropped to a low of 20% in 2016.

There were many prognosis from the “experts” who tried to explain this including “Malaysian retail investors have limited funds to invest in the stock market, retail investors don’t understand the stock market, they only buy speculative and penny stocks and Malaysian retail investors buy unit trusts instead of stocks so you should count unit trusts as part of retail participation.”

So, what is the combined “fire power” of retail investors in Malaysia? How much money do they have?

Excluding disposal income used for household expenditure, if you add the total amount of money that individuals have in their savings accounts in the banks, the amount of money invested in unit trusts and the ownership of stocks by individuals is close to RM1.6 trillion.

This compares with about RM870bil in the Employees Provident Fund (EPF) and close to RM200bil in the Retirement Fund Inc (KWAP).

Everyone knows that the EPF and KWAP, classified by Bursa Malaysia as local institutions, are major players on the stock exchange.

The other players who make up this category are the local fund management companies.

Local institutions have traditionally accounted for about 50% to 60% of all trading volume on Bursa Malaysia.

One factor often overlooked by most is that these local institutions do not put all their funds into stocks.

In fact, the majority of the funds are invested in money market instruments (like deposits) and fixed income (government and corporate bonds).

This is especially true for the government-linked investment companies as they have strict asset allocation policies that govern how they invest.

Funds are allocated into various assets classes, each with a different risk profile. Equities are generally considered high-risk assets therefore the allocation is often less compared with the other asset classes.

Unlike institutional funds, retail investors have no such restriction, they buy what they want and is only limited by how much money they have.

Another factor is leveraging.

Retail investors can borrow money to buy stocks. Most, if not all local institutions cannot borrow money for investments.

Another commonly accepted perception about retail investors is they only buy speculative and penny stocks.

This perception has also been debunked by the recent behaviour of the retail investors – there is a pandemic coming, so buy gloves stocks.

In addition, it is a well-known fact that Malaysian glove companies are global leaders in the manufacturing of gloves. There is no need for a 20-page research report to come to this simple decision to buy glove stocks. Glove stocks are definitely not penny stocks. Before the pandemic, the share price of Top Glove, Hartalega, Kossan and Supermax as at the end of January were RM5.85, RM5.92, RM4.90 and RM1.78 respectively.

Retail investors are still buying Top Glove Corp Bhdshares at above RM20 as seen in the latest rebound of the stock after some negative news.

The growth in retail participation is also helped by the transformation of digitalisation of the broking industry. Platforms like Rakuten Trade, which allow quick online account opening have certainly increased retail participation. This was certainly true during the movement control order when face-to-face account opening was not possible. The industry will see the benefits of going digital after this.

Bursa...Top 3 in Asia...???

Bursa stock gallery

NOBODY would have guessed that the daily trading volume record on Bursa Malaysia would be broken this year. When the Covid-19 crisis hit, most people were focused on the gloom and doom from the fallout of the pandemic.

Bursa Malaysia’s trading volume and trading value hit a record 9.3 billion units and RM9.4bil on May 29.

It is also not a one-day affair.

There were many 44 days when volumes were 50% to 100% higher than the average of Bursa Malaysia’s trading volume and values of 2.7 billion units and RM2.4bil respectively in the last two years.

To be fair, it is not just a Malaysian phenomenon, a few other markets, for example those in the United States and Hong Kong also experienced similar surges in trading volumes.

The “star” contributors to the surge in trading volume are not the usual big local institutions.

It is also not contributed by strong inflows from global foreign institutional funds.

There is no foreign “hot money” this time. In fact, foreign institutions have been selling Malaysian stocks since two years ago and remained very much absent this time around.

Retail investors were big contributors to the high trading volumes this year. Retail participation reached a high of 40% last month. Many people would not have believed it, especially if one were to study the slow decline in retail participation on Bursa Malaysia over the last 10 years.

In 2009, retail participation was over 30% and it has gradually dropped to a low of 20% in 2016.

There were many prognosis from the “experts” who tried to explain this including “Malaysian retail investors have limited funds to invest in the stock market, retail investors don’t understand the stock market, they only buy speculative and penny stocks and Malaysian retail investors buy unit trusts instead of stocks so you should count unit trusts as part of retail participation.”

So, what is the combined “fire power” of retail investors in Malaysia? How much money do they have?

Excluding disposal income used for household expenditure, if you add the total amount of money that individuals have in their savings accounts in the banks, the amount of money invested in unit trusts and the ownership of stocks by individuals is close to RM1.6 trillion.

This compares with about RM870bil in the Employees Provident Fund (EPF) and close to RM200bil in the Retirement Fund Inc (KWAP).

Everyone knows that the EPF and KWAP, classified by Bursa Malaysia as local institutions, are major players on the stock exchange.

The other players who make up this category are the local fund management companies.

Local institutions have traditionally accounted for about 50% to 60% of all trading volume on Bursa Malaysia.

One factor often overlooked by most is that these local institutions do not put all their funds into stocks.

In fact, the majority of the funds are invested in money market instruments (like deposits) and fixed income (government and corporate bonds).

This is especially true for the government-linked investment companies as they have strict asset allocation policies that govern how they invest.

Funds are allocated into various assets classes, each with a different risk profile. Equities are generally considered high-risk assets therefore the allocation is often less compared with the other asset classes.

Unlike institutional funds, retail investors have no such restriction, they buy what they want and is only limited by how much money they have.

Another factor is leveraging.

Retail investors can borrow money to buy stocks. Most, if not all local institutions cannot borrow money for investments.

Another commonly accepted perception about retail investors is they only buy speculative and penny stocks.

This perception has also been debunked by the recent behaviour of the retail investors – there is a pandemic coming, so buy gloves stocks.

In addition, it is a well-known fact that Malaysian glove companies are global leaders in the manufacturing of gloves. There is no need for a 20-page research report to come to this simple decision to buy glove stocks. Glove stocks are definitely not penny stocks. Before the pandemic, the share price of Top Glove, Hartalega, Kossan and Supermax as at the end of January were RM5.85, RM5.92, RM4.90 and RM1.78 respectively.

Retail investors are still buying Top Glove Corp Bhdshares at above RM20 as seen in the latest rebound of the stock after some negative news.

The growth in retail participation is also helped by the transformation of digitalisation of the broking industry. Platforms like Rakuten Trade, which allow quick online account opening have certainly increased retail participation. This was certainly true during the movement control order when face-to-face account opening was not possible. The industry will see the benefits of going digital after this.

yttihs @geary Monday careful with Careplus. It may open high then IB profit takes. May not even push it high. Of course, it can be that they push it higher. Just a word of caution
24/07/2020 10:58 PM

Yup...good advice...when u expect it...it won't happen...just buy n don't expect so much...maybe not so much margin on it...good day...!!!

vespa Careplus' growth is explosive. By end 2021 it would have doubled its output
24/07/2020 10:55 PM

EPS...@0.13...FY...2021...(・o・)

Yu_and_Mee 110 is next year June target.
60 is this year end.
24/07/2020 10:13 PM.

U are probably correct...provided WHO... haven't announce Covid-19 is endemic...(・o・)

Careplus Group Bhd went back into the black for the second quarter ended June 30, 2020 (2QFY20), posting a net profit of RM36.21 million, of which RM15.4 million was registered as one-off gain from a stake disposal. Quarterly revenue increased 26.9% to RM118.9 million, from RM86.9 million in the corresponding quarter last year.

The group said it will double its total production capacity to 8.8 billion pieces by end-2021 from 4.1 billion pieces currently – with a total of 50 production lines by then.

Monday hentam Careplus with free cash n margin...◉‿◉

peter555 wao lao eh careplus profit .. Qtr on Qtr up 3,073.71% Yr on Yr 1,946.61% .. imagine what would be TG profit than ... fly liao la next week all glove counters
24/07/2020 8:28 PM

Gloves cruise ships are sailing in the middle on the oceans...u need a helicopter at higher cost to jump inside...still have few baggers to grab...or maybe more...if covid19 still in pandemic...Unless WHO announce it's endemic...!!!

KUALA LUMPURL: Glove maker Careplus Group Bhdturned a huge profit in second quarter ended June 30 boosted by strong demand worldwide for the protective gear.

The number of Covid-19 infection worldwide continue to accelerate this week, with total confirmed cases rising above the 15.5 million people mark.

Careplus said the global pandemic caused by the Covid-19 virus have created an exponential increase in demand for medical gloves which have benefited many manufacturers.

For the three-month ended June 30, revenue climbed 37% to RM118.9mil, while net profit soared to RM36.3mi, or 6.7 sen a share.

"The average selling prices have surged during the pandemic period which is expected to continue until vaccines have been developed and administered globally," Careplus said in a filing with Bursa Malaysia today.

It said while spot average selling price (ASP) remain high, the ASP for regular buyers is expected to increase in the coming quarter barring any significant change to current shortage of supply.

"The Group therefore expects strong positive results in this pandemic period and beyond," Careplus added.

Meanwhile, the worsening COVID-19 pandemic has accelerated the company's plan to increase the production capacity.

By end of this year, ten new production lines will be installed and commissioned, while another thirteen new production lines will be installed and commissioned next year.

"This will nearly double the total production capacity from 4.1 billion pieces to about 8.8 billion pieces by end of 2021 barring any interruption," Careplus said.

The Group will have a total of 50 production lines by end of 2021.

yttihs I congratulate Careplus holder. Hope you earn kao kao
24/07/2020 6:46 PM

Monday guaranteed limit up...lowest PE...amongst all gloves counters...!!!

geary yttihs If you apply 1946% to TG siao oh.
24/07/2020 6:45 PM

TG...maybe around...@600%...^^^
24/07/2020 6:52 PM

TG...EPS will be around...@0.40...multiple by present...PE...100...RM40.00...｡◕‿◕｡

yttihs If you apply 1946% to TG siao oh.
24/07/2020 6:45 PM

TG...maybe around...@600%...^^^

Careplus.
[Registration No. 201001011474 (896134-D)]
(Incorporated in Malaysia)
Unaudited Quarterly Financial Report for the 2nd Quarter Ended 30 June 2020
1 | P a g e
Unaudited Condensed Consolidated Statements of Profit or Loss and Other
Comprehensive Income
Current Period
Quarter
Preceding
Period
Corresponding
Quarter
Current Period
To Date
Preceding
Period
Corresponding
To Date
30-Jun-2020 30-Jun-2019 30-Jun-2020 30-Jun-2019
RM'000 RM'000 RM'000 RM'000
Revenue 118,898 86,898 223,594 172,047
Cost of sales (91,610) (85,135) (191,045) (165,435)
Gross profit 27,288 1,763 32,549 6,612
Other operating income/(expense) 15,059 (82) 14,461 (385)
Administration expenses (3,821) (2,550) (6,022) (4,901)
Finance costs (1,293) (1,292) (2,549) (2,692)
Shares of profit in joint venture 886 - 886 -
Profit/(loss) before taxation 38,119 (2,161) 39,325 (1,366)
Taxation (1,907) 107 (1,972) (170)
Profit/(loss) after taxation 36,212 (2,054) 37,353 (1,536)
Other comprehensive income, net
of tax - - - -
Total comprehensive income/(loss)
for the financial period 36,212 (2,054) 37,353 (1,536)
Profit/(Loss) after taxation:
Owners of the Company 36,212 (1,961) 37,353 (1,598)
Non-controlling interest - (93) - 62
36,212 (2,054)

Wow net margin...@>30%...Then Topglove...???

Changes in Director's Interest (Section 219 of CA 2016)
TOP GLOVE CORPORATION BHD

Information Compiled By KLSE

Particulars of Director
Name DATO' LIM HAN BOON
Descriptions(Class) Ordinary Shares
Details of changes
No
Date of change
No of securities
Type of transaction
Nature of Interest
1
21/07/2020
20,000
Acquired
Direct Interest
Name of registered holder Dato' Lim Han Boon
Description of "Others" Type of Transaction
Consideration (if any) RM24.7750 Per Share

Circumstances by reason of which change has occurred Acquisition of shares.
Nature of interest Direct Interest
Total no of securities after change
Direct (units) 80,000
Direct (%) 0.003
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice 23/07/2020
Date notice received by Listed Issuer 23/07/2020


Remarks :
Balance of Shares:

Direct interest: 80,000

This announcement also serves as announcement pursuant to Paragraph 14.09(a) of the Main Market Listing Requirements for dealing in listed securities outside closed period. The number of shares and percentage of the total issued shares of Top Glove Corporation Bhd involved is 20,000 (0.0007%).

This announcement is dated 24 July 2020.

Announcement Info
Company Name TOP GLOVE CORPORATION BHD
Stock Name TOPGLOV
Date Announced 24 Jul 2020
Category Changes in Director's Interest Pursuant to Section 219 of CA 2016
Reference Number CS4-23072020-00025

lazy to explain....mau mati, pergi mati saja lar

Correct so many different types of mentality... that's why UK don't have genius anymore...5G also need Japan, Sweden or Norway to help.. blessings all gone because they bullied so many countries during the 29th century. Now US turn...lack of hardworking n geniuses there...must only like to talk rubbish n enjoy life...never create blessings...ಠ︵ಠ

Max2838 Careplus buys hotel for workers. Now every room has aircon n attached bathroom.
Foreign workers living standard upgraded from culvert stay to hotel stay , so why Al-Jeera complaining? No hand soap n shampoo?
24/07/2020 4:09 PM

Call them to fly kite loh...cannot buy themselves...living standard so... bloody good... complain spa LAGI mahu...ಠ ೧ ಠ

stevenckheng it is public bank, beh song rank lower
24/07/2020 3:48 PM

｡◕‿◕｡

Pudu's Ah Fah ( Vegetable Seller) ok, we go to the wars! bring out the cleavers
24/07/2020 3:22 PM

During the Korean War...Chinese army using cleavers also pushed back all the US n UN armies...Now u dare to bully China...Trump is a businessman...he isn't stupid...probably he got big business contacts...that's he always barks like crazy dog...but he isn't crazy...$$$...all inside his big pocket...even though he take US 1...for his monthly salary...ʘ‿ʘ

ongong2020 Investors have to weight the cost-benefit analysis of the two giants going into war before panic sell down. If war can create more benefits to the country interest, then it will happen. But declaring war during the pandemic situation, hmmm...

This US n Trump act like world police...but their time are slowly gone...they are afraid of fatty Kim...what about Russia...so no point talking about the old cold war...not 5G going...6G...China is advancing...the west are declining...◉‿◉

smallkid91 (◉‿◉)
^^^^^^^^

@geary reminds me of that cimb octopus mascot.
24/07/2020 2:19 PM

sunra88 Trade war if cannot source gloves from china will need to buy from who?
24/07/2020 2:20 PM

smallkid91 ~~~
~~~~

(◉‿◉)
^^^^^^^^
~~
~ ~
24/07/2020 2:20 PM

◉‿◉｡◕‿◕｡ʘ‿ʘ

Cannot buy from China companies...aiyoo...buy from TopGlove lah...the most famous gloves company in the world...ʘ‿ʘ

China’s Foreign Ministry announced Friday that it is revoking the license for the U.S. consulate general in the southwestern Chinese city of Chengdu.
The Chengdu consular district covers the controversial autonomous region of Tibet, the municipality of Chongqing, and the provinces of Sichuan, Yunnan and Guizhou, according to the consulate’s website.
The announcement comes after the U.S. ordered China to close its consulate in Houston, citing efforts to protect American intellectual property and the private information of its citizens.

Geopolitical tension...Slight negative sentiment...This is how Mr. Market lives his life all the time...he don't care...but do u care...n in which way u think it can benefit U...◉‿◉

sampooler lanikai.. u are right... hold until 22/23, price will be rm2.5

Upside will be huge by then...Maybe...@7.00...◉‿◉

KUALA LUMPUR (July 23): Top Glove Corp Bhd is now second only to Malayan Banking Bhd (Maybank) in terms of market capitalisation (cap).

At today's close, the country's largest banking group has a market cap of RM88.58 billion.

At its market cap of RM70.45 billion, Top Glove has surpassed Public Bank Bhd (valued at RM69.57 billion) and Tenaga Nasional Bhd (RM64.69 billion) by a margin of RM1 billion.


Top Glove was again the top gainer on Bursa Malaysia today, closing RM1.42 or 5.75% higher at its record high of RM26.12.

Despite logging a 455% gain year-to-date, the bullish sentiment among analysts covering Top Glove remains unfettered.

Of the gloves' bull, Affin Hwang Capital Research analyst Ng Chi Hoong earlier this week raised his target price for Top Glove from RM22.40 to RM46.40, hinging on a price-earnings ratio (PER) of 30 times on forecast earnings.

Notably, if Top Glove's shares reach RM46.40 apiece, this would mean that its market cap will reach RM125 billion, surpassing that of Maybank by a comfortable 40% margin.

Ng even thinks investors may ascribe a higher valuation due to its strong earnings growth outlook and ponders the possibility of Top Glove breaching RM100 per share should investors peg a PER of 52 times to it, similar to Hartalega's valuation.

If Top Glove were to trade at RM100 apiece, this would mean its market cap will reach a whopping RM269 billion. In fact, there has not been any Malaysian-listed company reaching the RM150 billion mark.

Ng's optimism is premised on a high possibility that Top Glove's average selling price (ASP) could be higher than his base case of 5% month-on-month increment, given the strong surge in glove demand.

"If selling prices were to increase by 8-10% month-on-month each month in FY21E, our earnings forecasts would be uplifted between 24%-42%," he said, adding that Top Glove could see direct earnings improvement due to operating leverage as cost does not increase in tandem with increase in ASP.

In terms of the tampering from US Customs and Border Protection detention order, Ng thinks the impact on Top Glove's earnings is manageable at around 5% to 6%.

Ng also believes that should any unfavourable circumstances transpire, Top Glove could reroute its orders for the US to other countries at spot prices, and that could in fact pose better margin for the glove maker as spot prices are generally higher by about 5%.

Upswing...5%...!!!

mbge7clt normally drop more after ex, maybe better strategy sell before ex and buy back lower after that.
23/07/2020 11:17 PM

Not really...Pentamaster was a good example...consolidating...then retrace...then some will buy back...provided company has strong history of earnings growth...it's a growth stock...good management that will return extra profits to shareholders...past, present n future...it will rebound...but won't take more than 200 days...for such a excellent company like...TopGlove...!!!

https://www.channelnewsasia.com/news/world/covid-19-vaccine-us-china-trump-12951908

myongcc5 50 is very possible given the lead time n ASP.
JUST HV TO B PATIENCE
23/07/2020 8:35 PM

Topglove n Supermax...#ASP margin up...@100%...Hartalega...maintaining...#Kossan...Rubberex...n probably Comfort up...@50%...All gloves Sales probably up...@50%...Sales n margin up...Profit sure up lah...Just buy n Hold...Sales n margin down...Sell...Very simple lah...investing so...headache meh...!!!

yingzhe17 All retirement funds in here. Time to pull out tomorrow to lock profit.
23/07/2020 7:58 PM

ಠ︵ಠ

stevenckheng next is who ? who is number 1 ? NESTLE?

Aiyoo...Of course it's...Maybank... TopGlove...above...RM30.00...No. 1...by next week...provided Maybank never limit up...◉‿◉

Top Glove Corp. has vaulted past Public Bank Bhd. to become the second most valuable stock on Malaysia’s equities benchmark, capping a dizzying rally by the rubber glove maker.

Shares of Top Glove, which ranked near the bottom of the FTSE Bursa Malaysia KLCI Index at the start of the year, closed Thursday with a market value of 70.4 billion ringgit ($16.5 billion), exceeding Public Bank’s 69.5 billion ringgit. The astonishing surge in Top Glove’s shares has closed the 63 billion ringgit gap at the beginning of 2020 between its market capitalization and that of Public Bank, the nation’s third largest lender by assets.

Bloomberg.

BEIJING: A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of a previous expectation it may become available in 2021.

Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.

Sinopharm's unit China National Biotec Group (CNBG), which is responsible for two coronavirus vaccine projects, said in June the shot may not be ready until at least 2021 as a lack of new infections in China made it difficult to find people to test it on.

But China has since found alternative trial sites abroad, overcoming some of the obstacles it faces in the global race to produce a vaccine to fight a pandemic that has killed over 600,000 people globally.

READ: China's Sinopharm begins late stage trial of COVID-19 vaccine in Abu Dhabi
Sinopharm's experimental shot has entered a Phase III trial involving around 15,000 participants and two vaccine strains in the United Arab Emirates.

Another potential vaccine, developed by Chinese firm Sinovac Biotech using a similar technology, has also been given to participants in a Phase III trial in Brazil.

A vaccine candidate developed by CanSino Biologics and China's military research unit, which appears to be safe and induced immune responses in most subjects in a closely-watched mid-stage study, is also looking for opportunities to run a Phase III trial outside China.

amateurJR Cant wait for tomorrow show. RM35 before bonus issue
23/07/2020 5:30 PM

Tomorrow us Friday...other counters depend on news n some FA...3 days no more shows...But for gloves counters at present scenarios...very hard to predict...n also some tech stocks...!!!

ChloeTai Welcome back to all vaccines investors. Hope that Pharma and Dpharma make money, here gloves make more money.
23/07/2020 5:20 PM

The more the merrier...Actually we can learn some IQ n lot of psychological sentiments or EQ of many traders n investors...learn from mistakes...n be a more productive traders or investors...!!!

Sold all...!!!

Alibaba Topglove overtook PB Bank today in market cap. Congratulation !

Next to overtake will be Maybank...Very Soon...!!!

yttihs 26 is nice. However, we have been here before.

The real challenge is 27. We have never been there.

So, we can champaigne if we are there. Right, now Starbucks only

Hahaha...my aim are...@62 n @72...hehehe...!!!

geary haha1234 pharma and dpharma is a total useless company compared to others around the world i can guarantee whoever go in now will burn their money that earn from glove into dust
23/07/2020 11:49 AM

As a middleman how much the profit margins...plus it's only in Malaysia's sales...n control by government policies n subsidies...then which countries want to buy from them...they aren't the producers...too much hype...(・o・)
23/07/2020 11:58 AM

Those who didnt take profit or sell Dpharma earlier...tomorrow is Friday...limit down again...up fast down also fast...as I said before some news...then 'goreng'...it won't last longer than gloves or some tech counters...the most three days...the musical stop...it's midnight...!!!

Up...｡◕‿◕｡

yttihs Performing CPR on Pharma...Doctor not yet pronounce dead...still got chance
23/07/2020 4:15 PM

◉‿◉｡◕‿◕｡ʘ‿ʘ